Achieve Better Outcomes
Blood volume measurement ends the debate by taking the guesswork out of determining a patient’s blood
volume status — significantly improving multiple measures of patient outcomes by enabling volume guided management.
Significantly Reduce Heart Failure Mortality & Readmissions
Propensity matched-control trial in community hospital | n = 245, Mixed HFpEF/HFrEF
Blood Volume Measurements Improved ICU Survival
Prospective randomized control trial in surgical ICU | n = 100, 70% Septic Shock/Sepsis/40% ARDS
36 Hour Earlier
44% Change in Treatment
Strategy Versus Standard Care
Excellent Value in Healthcare
Blood Volume-Guided Treatment Extremely Cost-Effective
Retrospective analysis in hospitalized heart failure patients | n = 245, Mixed HFpEF/HFrEF
Well above the 0.227 previously reported
Far below the ICER threshold of $50,000
Approved for Reimbursement
Surgical Blood Loss
Where Blood Volume Measurement Makes an Impact
In the Spotlight
Watch Daxor CEO, Michael Feldschuh, Discuss How BVA-100 Technology is Joining to Fight COVID-19
Published Research from Leading Institutions Has Established
the Value of Blood Volume Measurement Using the BVA-100 Test
Columbia University, Duke Health, Geisinger, Mayo Clinic, New York University,
Yale University, Vanderbilt University, Virginia Commonwealth University
Published Research from Leading Institutions
Has Established the Value of the BVA-100 Test
Columbia University, Duke Health, Geisinger, Mayo Clinic, New York University, Yale University, Vanderbilt University, Virginia Commonwealth University
Understanding More for
Providers, Payers, Patients
News & Events
Daxor Featured in the SNMMI Value Initiative Newsletter
Modeling Excellence: Implementation of BVA for Precision HF Management
Partner With the Dedicated Leader in BVA
As the pioneer in blood volume analysis, Daxor provides education and the resources needed to ensure easy onboarding along with continuing support to drive maximum value from your BVA system throughout your facility. With a long-standing commitment to improving care and numerous studies validating our technology, Daxor is completely focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. Our vision is optimal blood volume for all.
Volume is Vital. End the Debate With Daxor.
Call us at 865-425-0555.
Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for use in a broad range of medical and surgical conditions.
Daxor Corporation – 107 Meco Lane, Oak Ridge, TN 37830
Phone: 865-425-0555 | Fax: 865-425-0551
email@example.com | daxor.com
ISO 13485 Certified
Made in the USA.
COPYRIGHT 2023 © DAXOR CORPORATION – ALL RIGHTS RESERVED.